Leukemia Clinical Trials

Showing 5521-5540 of 8,366 trials

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia

NCT03672851

This is a single arm, open-label, phase 1 study, to determine the safety and efficacy of anti-CD123 CAR-T cells in treating patients diagnosed with refractory/relapsed acute leukemia in a dose-escalation way.

Acute LeukemiaAcute Leukemia in RelapseAcute Myeloid Leukemia+1 more

Second Affiliated Hospital of Xi'an Jiaotong University2 participantsStarted Apr 2019

Xi'an, Shaanxi, China

COMPLETED

Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula

NCT03769051

The main purpose of this study was to observe the effect of amino acid formula on infants with cow's milk protein allergy; to evaluate the role of food avoidance and Open Food Challenge test in the diagnosis of infants with cow's milk protein allergy; to observe the allergic process in infants with cow's milk protein allergy and to explore the criteria for diagnosis and treatment.

Cow's Milk Protein Allergy

Peking University Third Hospital200 participantsStarted Jun 2015

UNKNOWNEARLY Phase 1

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

NCT03910842

This is a single arm, open-label, early phase Ⅰ study, to determine the safety and efficacy of CD19-TriCAR-T and CD19-TriCAR-SILK cell therapy in Children CD19+ Leukemia Non-Hodgkin lymphoma treatment.

Non-Hodgkin Lymphoma of IntestineLeukemia

Timmune Biotech Inc.12 participantsStarted Mar 2019

Changsha, Hunan, China

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia

Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Related Searches

Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery

A Novel Biologic Therapy for Perennial Allergic Rhinitis

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer

Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device

Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA

Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy

Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC

Detection of Circulating Biomarkers of Immunogenic Cell Death

Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy